ICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature Review.

ACTH, adrenocorticotropic hormone BAL, bronchoalveolar lavage fluid analysis CRH, corticotropin-releasing hormone FDG, 18F-fluorodeoxyglucose FSH, follicle-stimulating hormone GH, growth hormone GHRP2, growth hormone-releasing peptide 2 ICAM1 ICAM1, intercellular adhesion molecule 1 IVLBCL, intravascular large B-cell lymphoma LDH, lactate dehydrogenase LH, luteinizing hormone LHRH, luteinizing hormone-releasing hormone MEAM, ranimustine, etoposide, cytarabine, and melphalan MTX, methotrexate R-CHOP, rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone R-hyper-CVAD/MA, rituximab plus hyper-fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and cytarabine TBLB, transbronchial lung biopsy TRH, thyrotropin-releasing hormone TSH, thyrotropin hypopituitarism intravascular large B-cell lymphoma pituitary sIL2R, soluble IL-2 receptor

Journal

AACE clinical case reports
ISSN: 2376-0605
Titre abrégé: AACE Clin Case Rep
Pays: United States
ID NLM: 101670593

Informations de publication

Date de publication:
Historique:
received: 22 10 2020
accepted: 27 01 2021
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

Intravascular large B-cell lymphoma (IVLBCL) is a rare and aggressive type of B-cell lymphoma with large cells growing within the lumen of blood vessels. Although previous reports revealed highly variable symptoms resulting from small-vessel occlusion by neoplastic cells in a variety of organs, there are few reports of IVLBCL with pituitary involvement. We present a case of IVLBCL with pituitary infiltration from our institution together with a literature review of similar cases to better understand this rare case of IVLBCL involving the pituitary gland. Our case and the pertinent literature demonstrated that IVLBCL with pituitary involvement predominantly occurred in women at a mean age of 64 years, and most of them showed panhypopituitarism that was reversible after standard therapy of rituximab-containing chemotherapy with intrathecal methotrexate. Notably, the pituitary biopsy in our case revealed that atypical large B-cells found within blood vessels and the pituitary gland were negative for intercellular adhesion molecule 1. Intercellular adhesion molecule 1-negative lymphoid cells may have contributed to panhypopituitarism by extravasation into the pituitary tissues, which do not have a blood-brain barrier and receive abundant blood flow. IVLBCL of the pituitary gland is a rare lymphoma with nonspecific manifestations and a dismal prognosis. Recognition of the clinicopathological features is necessary for early clinical diagnosis and appropriate treatment.

Identifiants

pubmed: 34307847
doi: 10.1016/j.aace.2021.01.011
pii: S2376-0605(21)00023-7
pmc: PMC8282537
doi:

Types de publication

Case Reports

Langues

eng

Pagination

249-255

Informations de copyright

© 2021 AACE. Published by Elsevier Inc.

Références

BMJ Case Rep. 2013 Jan 28;2013:
pubmed: 23362070
Haematologica. 2002 Jun;87(6):ECR21
pubmed: 12031934
Hum Pathol. 2000 Feb;31(2):220-6
pubmed: 10685637
Am J Hematol. 2016 Nov;91(11):1167-1168
pubmed: 27387341
Indian J Pathol Microbiol. 2012 Oct-Dec;55(4):549-51
pubmed: 23455803
Haematologica. 2002 Nov;87(11):ECR36
pubmed: 12414362
Blood. 2011 May 12;117(19):5019-32
pubmed: 21300984
Blood. 2007 Jan 15;109(2):478-85
pubmed: 16985183
J Neurooncol. 1991 Oct;11(2):171-80
pubmed: 1744685
Pituitary. 2010;13(1):39-47
pubmed: 19707877
Endocrine. 2008 Aug-Dec;34(1-3):11-6
pubmed: 18937075
Hematol Oncol. 1989 May-Jun;7(3):195-206
pubmed: 2651272
Cancer. 1994 Mar 15;73(6):1738-45
pubmed: 8156502
Arch Pathol Lab Med. 2012 Mar;136(3):333-8
pubmed: 22372911
Am J Surg Pathol. 1986 Feb;10(2):112-23
pubmed: 2420221
Eur J Endocrinol. 2007 Jul;157(1):19-27
pubmed: 17609397
J Neuroophthalmol. 2012 Mar;32(1):33-7
pubmed: 22173269
Wien Klin Wochenschr. 2006 Jul;118(13-14):422-5
pubmed: 16865648
Am J Med. 1999 Aug;107(2):169-76
pubmed: 10460050
Case Rep Hematol. 2019 Apr 28;2019:9625075
pubmed: 31183225
Br J Haematol. 2018 Jun;181(6):851-852
pubmed: 28439895
Tohoku J Exp Med. 2016;238(3):197-203
pubmed: 26936510

Auteurs

Kumiko Naito (K)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Sawako Suzuki (S)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Chikako Ohwada (C)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Hematology, Chiba University Hospital, Chiba, Japan.

Kazuki Ishiwata (K)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Yutaro Ruike (Y)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Akiko Ishida (A)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Hanna Deguchi-Horiuchi (H)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Masanori Fujimoto (M)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Hisashi Koide (H)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Emiko Sakaida (E)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Hematology, Chiba University Hospital, Chiba, Japan.

Kentaro Horiguchi (K)

Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.

Yasuo Iwadate (Y)

Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.

Ichiro Tatsuno (I)

Center for Diabetes, Metabolism and Endocrinology, Toho University Sakura Medical Center, Chiba, Japan.

Naoko Inoshita (N)

Department of Pathological Diagnosis, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.

Jun-Ichiro Ikeda (JI)

Department of Pathology, Chiba University Hospital, Chiba, Japan.

Tomoaki Tanaka (T)

Department of Molecular Diagnosis, Chiba University, Chiba, Japan.

Koutaro Yokote (K)

Department of Endocrinology, Hematology and Gerontology, Chiba University Hospital, Chiba, Japan.
Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, Chiba, Japan.

Classifications MeSH